Skip to content
drillr.ai
Sign up

GRCE

Grace Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$2.10
−1.87%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue—————
Cost of Revenue2.0K————
Gross Profit(2.0K)————
Operating Expenses
R&D Expense2.5M2.4M13.5M6.4M13.5M
SG&A Expense7.5M8.7M10.2M9.0M11.1M
General & Admin Expense7.5M8.7M10.2M9.0M10.9M
Selling & Marketing Expense————183.9K
Other Expenses15.7M7.0K10.0K2.1M45.9M
Total Operating Expenses25.7M11.1M23.8M17.4M70.5M
Cost and Expenses25.7M11.1M23.8M17.4M70.5M
Operating Income (EBIT)(25.7M)(11.1M)(23.8M)(17.4M)(70.5M)
Non-Operating
Interest Income684.3K685.0K711.0K911.0K246.0K
Interest Expense—————
Net Interest Income684.3K685.0K711.0K911.0K246.0K
Other Non-Op Income/Expense2.5M1.6M5.6M(2.5M)248.9K
Non-Operating Income (excl Interest)———(2.0M)(45.9M)
EBT (Pre-Tax Income)(23.2M)(9.5M)(18.2M)(19.9M)(70.3M)
Income Tax Expense(1.7M)(1.7M)(4.6M)(2.5M)(12.9M)
Bottom Line
Net Income(21.5M)(7.8M)(13.6M)(17.4M)(57.4M)
Earnings from Cont. Ops(21.5M)(7.8M)(13.6M)(17.4M)(57.4M)
Earnings from Discont. Ops—————
Bottom Line Net Income(21.5M)(7.8M)(13.6M)(17.4M)(57.4M)
Per Share
Basic EPS($1.26)($0.47)($1.13)($1.83)($7.72)
Diluted EPS($1.26)($0.47)($1.13)($1.83)($7.72)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding17.3M16.5M12.1M9.5M7.4M
Diluted Shares Outstanding17.3M16.5M12.1M9.5M7.4M
Profitability Metrics
EBITDA(25.7M)(11.1M)(23.7M)(15.4M)(24.5M)
D&A9.5K7.0K10.0K54.3K167.7K
EBIT(25.7M)(11.1M)(23.8M)(15.4M)(24.7M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026